整形科

订阅

MedSci主页 / 所有栏目 / 整形科

预告来袭：梅斯医学 · 对话皮科人物专访

2022-08-29 MedSci原创 MedSci原创

梅斯专栏对话皮科
关注

中国银屑病联盟、梅斯医学共同出品，对话20位中国资深皮肤专家。不同的医疗人生，同样的真心热忱。

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1703370, encodeId=ab3a1e0337018, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Aug 31 22:06:56 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098190, encodeId=ed41209819000, content=对话皮科专家, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221122/7a66931fb1d64aeb85acdead53cb1518/4658ac5613a74430a37e5fe5ffaface5.jpg, createdBy=e9595636456, createdName=冻柠茶唔该, createdTime=Thu Nov 03 10:28:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242047, encodeId=d08f124204e66, content=学习受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=740c8168022, createdName=ms5000002137275276, createdTime=Tue Aug 30 14:15:31 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277374, encodeId=0ab912e737415, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Aug 31 02:06:56 CST 2022, time=2022-08-31, status=1, ipAttribution=)]
    2022-08-31 flyingeagle87

    #专访#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1703370, encodeId=ab3a1e0337018, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Aug 31 22:06:56 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098190, encodeId=ed41209819000, content=对话皮科专家, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221122/7a66931fb1d64aeb85acdead53cb1518/4658ac5613a74430a37e5fe5ffaface5.jpg, createdBy=e9595636456, createdName=冻柠茶唔该, createdTime=Thu Nov 03 10:28:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242047, encodeId=d08f124204e66, content=学习受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=740c8168022, createdName=ms5000002137275276, createdTime=Tue Aug 30 14:15:31 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277374, encodeId=0ab912e737415, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Aug 31 02:06:56 CST 2022, time=2022-08-31, status=1, ipAttribution=)]
    2022-11-03 冻柠茶唔该

    对话皮科专家

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1703370, encodeId=ab3a1e0337018, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Aug 31 22:06:56 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098190, encodeId=ed41209819000, content=对话皮科专家, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221122/7a66931fb1d64aeb85acdead53cb1518/4658ac5613a74430a37e5fe5ffaface5.jpg, createdBy=e9595636456, createdName=冻柠茶唔该, createdTime=Thu Nov 03 10:28:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242047, encodeId=d08f124204e66, content=学习受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=740c8168022, createdName=ms5000002137275276, createdTime=Tue Aug 30 14:15:31 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277374, encodeId=0ab912e737415, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Aug 31 02:06:56 CST 2022, time=2022-08-31, status=1, ipAttribution=)]
    2022-08-30 ms5000002137275276

    学习受教

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1703370, encodeId=ab3a1e0337018, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Aug 31 22:06:56 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098190, encodeId=ed41209819000, content=对话皮科专家, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221122/7a66931fb1d64aeb85acdead53cb1518/4658ac5613a74430a37e5fe5ffaface5.jpg, createdBy=e9595636456, createdName=冻柠茶唔该, createdTime=Thu Nov 03 10:28:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242047, encodeId=d08f124204e66, content=学习受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=740c8168022, createdName=ms5000002137275276, createdTime=Tue Aug 30 14:15:31 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277374, encodeId=0ab912e737415, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Aug 31 02:06:56 CST 2022, time=2022-08-31, status=1, ipAttribution=)]
    2022-08-31 一闲

    #梅斯#

    0

相关资讯

梅斯专栏：肿瘤新前沿——对话肿瘤

对话肿瘤，思索未来